These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

429 related articles for article (PubMed ID: 32969788)

  • 1. Sensitive Detection of SARS-CoV-2-Specific Antibodies in Dried Blood Spot Samples.
    Morley GL; Taylor S; Jossi S; Perez-Toledo M; Faustini SE; Marcial-Juarez E; Shields AM; Goodall M; Allen JD; Watanabe Y; Newby ML; Crispin M; Drayson MT; Cunningham AF; Richter AG; O'Shea MK
    Emerg Infect Dis; 2020 Dec; 26(12):2970-2973. PubMed ID: 32969788
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of Dried Blood Spots and Venous Blood for the Detection of SARS-CoV-2 Antibodies in a Population of Nursing Home Residents.
    Meyers E; Heytens S; Formukong A; Vercruysse H; De Sutter A; Geens T; Hofkens K; Janssens H; Nys E; Padalko E; Deschepper E; Cools P
    Microbiol Spectr; 2021 Oct; 9(2):e0017821. PubMed ID: 34549995
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A surrogate virus neutralization test to quantify antibody-mediated inhibition of SARS-CoV-2 in finger stick dried blood spot samples.
    Sancilio AE; D'Aquila RT; McNally EM; Velez MP; Ison MG; Demonbreun AR; McDade TW
    Sci Rep; 2021 Jul; 11(1):15321. PubMed ID: 34321523
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of a high-throughput SARS-CoV-2 antibody testing pathway using dried blood spot specimens.
    Moat SJ; Zelek WM; Carne E; Ponsford MJ; Bramhall K; Jones S; El-Shanawany T; Wise MP; Thomas A; George C; Fegan C; Steven R; Webb R; Weeks I; Morgan BP; Jolles S
    Ann Clin Biochem; 2021 Mar; 58(2):123-131. PubMed ID: 33269949
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of Dried Blood Spot Testing for SARS-CoV-2 Serology Using a Quantitative Commercial Assay.
    Brinc D; Biondi MJ; Li D; Sun H; Capraru C; Smookler D; Zahoor MA; Casey J; Kulasingam V; Feld JJ
    Viruses; 2021 May; 13(6):. PubMed ID: 34067361
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SARS-CoV-2 Antibody Binding and Neutralization in Dried Blood Spot Eluates and Paired Plasma.
    Itell HL; Weight H; Fish CS; Logue JK; Franko N; Wolf CR; McCulloch DJ; Galloway J; Matsen FA; Chu HY; Overbaugh J
    Microbiol Spectr; 2021 Oct; 9(2):e0129821. PubMed ID: 34668728
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of dried blood spot samples for SARS-CoV-2 antibody detection using the Roche Elecsys ® high throughput immunoassay.
    Mulchandani R; Brown B; Brooks T; Semper A; Machin N; Linley E; Borrow R; Wyllie D;
    J Clin Virol; 2021 Mar; 136():104739. PubMed ID: 33588354
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Validation of dried blood spot sample modifications to two commercially available COVID-19 IgG antibody immunoassays.
    Zava TT; Zava DT
    Bioanalysis; 2021 Jan; 13(1):13-28. PubMed ID: 33319585
    [No Abstract]   [Full Text] [Related]  

  • 9. Parameters of immunoglobulin extraction from dried blood spot cards and immunoassays for detection of antibody response to pathogens including the novel SARS-CoV-2.
    Iankov I; Viker K; Turgeon C; Matern D; Galanis E
    J Immunol Methods; 2021 May; 492():112996. PubMed ID: 33582147
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of dried blood spots as alternative sampling material for serological detection of anti-SARS-CoV-2 antibodies using established ELISAs.
    Weisser H; Steinhagen K; Höcker R; Borchardt-Lohölter V; Anvari Ö; Kern PM
    Clin Chem Lab Med; 2021 Apr; 59(5):979-985. PubMed ID: 33554537
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A dried blood spot protocol for high throughput analysis of SARS-CoV-2 serology based on the Roche Elecsys anti-N assay.
    Beyerl J; Rubio-Acero R; Castelletti N; Paunovic I; Kroidl I; Khan ZN; Bakuli A; Tautz A; Oft J; Hoelscher M; Wieser A;
    EBioMedicine; 2021 Aug; 70():103502. PubMed ID: 34333234
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High seroprevalence for SARS-CoV-2 among household members of essential workers detected using a dried blood spot assay.
    McDade TW; McNally EM; Zelikovich AS; D'Aquila R; Mustanski B; Miller A; Vaught LA; Reiser NL; Bogdanovic E; Fallon KS; Demonbreun AR
    PLoS One; 2020; 15(8):e0237833. PubMed ID: 32797108
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improved diagnosis of SARS-CoV-2 by using nucleoprotein and spike protein fragment 2 in quantitative dual ELISA tests.
    De Marco Verissimo C; O'Brien C; López Corrales J; Dorey A; Cwiklinski K; Lalor R; Doyle JM; Field S; Masterson C; Ribes Martinez E; Hughes G; Bergin C; Walshe K; McNicholas B; Laffey JG; Dalton JP; Kerr C; Doyle S
    Epidemiol Infect; 2021 Jun; 149():e140. PubMed ID: 34099081
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fully automated dried blood spot sample handling and extraction for serological testing of SARS-CoV-2 antibodies.
    Gaugler S; Sottas PE; Blum K; Luginbühl M
    Drug Test Anal; 2021 Jan; 13(1):223-226. PubMed ID: 33119946
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Validation of dried blood spot sampling for detecting SARS-CoV-2 antibodies and total immunoglobulins in a large cohort of asymptomatic young adults.
    Ferentinos P; Snape D; Koivula F; Faustini S; Nicholson-Little A; Stacey M; Gifford R; Parsons I; Lamb L; Greeves J; O'Hara J; Cunningham AF; Woods D; Richter A; O'Shea MK
    J Immunol Methods; 2023 Jul; 518():113492. PubMed ID: 37201783
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Multiplex Noninvasive Salivary Antibody Assay for SARS-CoV-2 Infection and Its Application in a Population-Based Survey by Mail.
    Egorov AI; Griffin SM; Fuzawa M; Kobylanski J; Grindstaff R; Padgett W; Simmons S; Hallinger DR; Styles JN; Wickersham L; Sams E; Hudgens E; Wade TJ
    Microbiol Spectr; 2021 Oct; 9(2):e0069321. PubMed ID: 34523986
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of SARS-CoV-2 IgG antibodies in dried blood spots.
    Turgeon CT; Sanders KA; Granger D; Nett SL; Hilgart H; Matern D; Theel ES
    Diagn Microbiol Infect Dis; 2021 Sep; 101(1):115425. PubMed ID: 34116343
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Validation of a new automated chemiluminescent anti-SARS-CoV-2 IgM and IgG antibody assay system detecting both N and S proteins in Japan.
    Yokoyama R; Kurano M; Morita Y; Shimura T; Nakano Y; Qian C; Xia F; He F; Kishi Y; Okada J; Yoshikawa N; Nagura Y; Okazaki H; Moriya K; Seto Y; Kodama T; Yatomi Y
    PLoS One; 2021; 16(3):e0247711. PubMed ID: 33661990
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rapid response flow cytometric assay for the detection of antibody responses to SARS-CoV-2.
    Lapuente D; Maier C; Irrgang P; Hübner J; Peter AS; Hoffmann M; Ensser A; Ziegler K; Winkler TH; Birkholz T; Kremer AE; Steininger P; Korn K; Neipel F; Überla K; Tenbusch M
    Eur J Clin Microbiol Infect Dis; 2021 Apr; 40(4):751-759. PubMed ID: 33078221
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Remote Fingerstick Blood Collection for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Antibody Testing.
    Garcia-Beltran WF; Miller TE; Kirkpatrick G; Nixon A; Astudillo MG; Yang D; Mahanta LM; Murali M; Dighe AS; Lennerz J; Thierauf J; Naranbhai V; Iafrate AJ
    Arch Pathol Lab Med; 2021 Apr; 145(4):415-418. PubMed ID: 33264390
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.